Laryngeal cancer
Laryngeal cancer is a relatively common malignant tumor, with an incidence rate of about 1-5% of all tumors in the body. It ranks third in the field of otolaryngology, second only to nasopharyngeal cancer and nasal and paranasal sinus cancer. The most common age is 50-70 years old. It is more common in men than in women, about 8:1, and the highest incidence rate is in Northeast China, North China and East China. The cause of the disease is not very clear, but the patients almost always have a long history of smoking. The symptoms vary depending on the vocal part of the tumor. Hoarseness may occur in the early stage of vocal cord cancer, while supraglottic cancer often manifests as discomfort in the throat or foreign body freezing, pain, and is often not obvious, which can easily delay diagnosis. In the late stage, obvious hoarseness, laryngeal sound, shortness of breath, difficulty breathing, pain, swallowing disorders, neck masses and cervical lymphadenopathy may occur.
-
Site of disease:
throat
-
Infectious :
Not contagious
-
Frequent population:
It is more common in males than females, about 8:1
-
Related symptoms:
Foreign body sensation in the throat
Throat blockage
Cough
Throat pain
Hoarseness
Related Drugs
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Guangdong Jianxin Pharmaceutical Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Shaanxi Bosen Biological Pharmaceutical Group Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Chongqing Lummy Pharmaceutical Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
XI'AN HAIXIN Pharmaceutical Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Yunnan Phyto Pharmaceutical Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Nanjing Pharmaceutical FACTORY Co., Ltd.
Sodium norcantharidate for injection
Indication: It has destructive and inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer.
Manufacturer:
Hainan Tongyong Kangli Pharmaceutical Co., Ltd.